Researchers developed a brain aging biomarker using DTI-ALPS imaging, which measures fluid flow along perivascular spaces in the glymphatic system. Testing 40,488 UK Biobank participants, they found this biomarker accurately predicted chronological age (r = 0.756) and correlated with telomere length and cognitive function. The brain age gap identified individuals with accelerated brain aging, linking to increased mortality risk from neurodegenerative and metabolic diseases. This represents a significant advance in brain aging research, as the glymphatic system—responsible for clearing metabolic waste from the brain—has only recently been recognized as crucial for neurological health. The sex-specific findings reveal musculoskeletal health drives brain aging in women while lung function matters more for men, suggesting personalized intervention strategies. Most practically significant was the discovery that systolic blood pressure below 120 mmHg strongly associated with reduced brain aging. This provides concrete evidence for aggressive blood pressure management as a brain protection strategy, moving beyond general cardiovascular benefits to specific neuroprotective effects. The identification of 154 aging-related proteins and 11 genetic loci opens new therapeutic targets, while the biomarker's validation across multiple datasets suggests clinical applicability for monitoring brain health interventions.